Sangamo Therapeutics, Inc. (SGMO)
0.149
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Sangamo Therapeutics Total Liabilities (Quarterly) : 78.92M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 78.92M |
| December 31, 2025 | 74.78M |
| September 30, 2025 | 82.40M |
| June 30, 2025 | 77.96M |
| March 31, 2025 | 81.26M |
| December 31, 2024 | 82.54M |
| September 30, 2024 | 72.13M |
| June 30, 2024 | 69.32M |
| March 31, 2024 | 72.26M |
| December 31, 2023 | 82.43M |
| September 30, 2023 | 84.78M |
| June 30, 2023 | 91.43M |
| March 31, 2023 | 104.96M |
| December 31, 2022 | 267.55M |
| September 30, 2022 | 284.76M |
| June 30, 2022 | 298.84M |
| March 31, 2022 | 319.79M |
| December 31, 2021 | 346.58M |
| September 30, 2021 | 366.38M |
| June 30, 2021 | 389.91M |
| March 31, 2021 | 407.68M |
| December 31, 2020 | 441.18M |
| September 30, 2020 | 442.83M |
| June 30, 2020 | 383.45M |
| March 31, 2020 | 189.86M |
| Date | Value |
|---|---|
| December 31, 2019 | 204.78M |
| September 30, 2019 | 220.89M |
| June 30, 2019 | 227.73M |
| March 31, 2019 | 213.55M |
| December 31, 2018 | 223.14M |
| September 30, 2018 | 226.70M |
| June 30, 2018 | 239.86M |
| March 31, 2018 | 98.80M |
| December 31, 2017 | 98.84M |
| September 30, 2017 | 83.14M |
| June 30, 2017 | 88.95M |
| March 31, 2017 | 21.13M |
| December 31, 2016 | 21.70M |
| September 30, 2016 | 21.14M |
| June 30, 2016 | 20.88M |
| March 31, 2016 | 17.64M |
| December 31, 2015 | 24.80M |
| September 30, 2015 | 28.96M |
| June 30, 2015 | 30.00M |
| March 31, 2015 | 31.02M |
| December 31, 2014 | 36.58M |
| September 30, 2014 | 37.21M |
| June 30, 2014 | 36.48M |
| March 31, 2014 | 38.08M |
| December 31, 2013 | 19.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| INmune Bio, Inc. | 6.194M |
| Bolt Biotherapeutics, Inc. | 28.20M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Oncolytics Biotech, Inc. | 13.29M |
| Sarepta Therapeutics, Inc. | 1.674B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.96M |
| Shareholders Equity (Quarterly) | -18.96M |
| Debt to Equity Ratio | -1.020 |
| Current Ratio | 0.6985 |
| Net Debt Paydown Yield | 2.20% |